US Broker Ratings

Krystal Biotech, Inc. (KRYS): Investor Outlook on a Promising 49.85% Upside Potential

Krystal Biotech, Inc. (KRYS), a burgeoning player in the biotechnology sector, is steadily carving a niche for itself by focusing on genetic medicines designed to address diseases with significant unmet..

Alkermes plc (ALKS) Stock Analysis: Unlocking Potential with a 25.93% Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, has recently attracted attention from investors due to a promising potential upside of 25.93%. With..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 52.91% Potential Upside

BridgeBio Pharma, Inc. (BBIO), a prominent player in the healthcare sector, specifically in biotechnology, offers a fascinating investment opportunity with significant potential upside. With a market capitalization of $7.33 billion,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 36.39% Upside Potential

Telix Pharmaceuticals Limited (TLX), a biopharmaceutical company based in North Melbourne, Australia, is capturing investor attention with its significant 36.39% potential upside. Operating primarily in the biotechnology sector, Telix specializes..

Glaukos Corporation (GKOS) Stock Analysis: Eyeing a 31.69% Potential Upside

Glaukos Corporation (NASDAQ: GKOS), a prominent player in the healthcare sector, is making waves with its innovative medical devices designed to treat a range of ophthalmic conditions. With a market..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Digital Healthcare Leader with Robust Revenue Growth

iRhythm Technologies, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry. Known for its cutting-edge cardiac monitoring technology, iRhythm has positioned itself..

Regencell Bioscience Holdings L (RGC): Investor Outlook on the Unique Growth Potential in Traditional Chinese Medicine

Regencell Bioscience Holdings Limited (RGC) presents an intriguing opportunity for investors looking to tap into the healthcare sector’s niche of Traditional Chinese Medicine (TCM). Headquartered in Causeway Bay, Hong Kong,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Pioneer with Robust Growth but Limited Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its cutting-edge medical devices designed to revolutionize organ transplant therapy. The company’s flagship offering, the Organ Care..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Biotech Innovator with 90% Revenue Growth and Strategic Focus on MS Treatment

TG Therapeutics, Inc. (NASDAQ: TGTX) has captured investor attention with its impressive 90.40% revenue growth and a strategic focus on developing treatments for B-cell mediated diseases. As a commercial-stage biopharmaceutical..

HealthEquity, Inc. (HQY) Investor Outlook: Strong Buy Ratings Signal Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is capturing the attention of investors with its robust position in the healthcare sector, specifically in the health information services industry. Based in Draper, Utah, the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unlocking a 69.73% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is drawing attention from investors with an enticing potential upside of 69.73%. Headquartered in Dublin, Ireland, this healthcare..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Promising 57% Upside in Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leading name in the healthcare sector, is making waves with its innovative approach to treating obstructive sleep apnea (OSA). Based in Golden Valley,..

Bio-Techne Corp (TECH) Investor Outlook: Analyzing a 41.61% Potential Upside Amid Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) is a noteworthy player in the biotechnology sector, offering a mix of life science reagents, instruments, and services. Headquartered in Minneapolis, Minnesota, the company operates through..

The Ensign Group, Inc. (ENSG) Stock Analysis: An 8.39% Upside in the Healthcare Sector

The Ensign Group, Inc. (ENSG), a stalwart in the healthcare sector, with a focus on medical care facilities, is capturing the attention of investors with its potential for growth and..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a 26% Potential Upside in Healthcare Plans

Oscar Health, Inc. (NYSE: OSCR) presents an intriguing opportunity for investors looking to tap into the healthcare sector, particularly within the realm of healthcare plans. As a company that operates..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Evaluating Growth Amidst a 4.04% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. The company, headquartered in Tarrytown, New..

Chemed Corp (CHE) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Chemed Corp (CHE), a prominent player in the healthcare sector, offers a unique mix of hospice care and commercial services through its VITAS and Roto-Rooter segments. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Closer Look at Valuation and Growth Prospects in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, presents a compelling case for investors with its robust revenue growth and strategic positioning in the..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a 31% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), operating within the dynamic healthcare sector, has garnered significant attention from investors due to its robust presence in the medical instruments and supplies industry. With a..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Growth with a 22.6% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, operates as a contract development and manufacturing company specializing in medical devices. With a market capitalization of $4.23..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds